Natera Future Growth
Future criteria checks 4/6
Natera is forecast to grow earnings and revenue by 71.4% and 14.3% per annum respectively. EPS is expected to grow by 72.3% per annum. Return on equity is forecast to be -3.8% in 3 years.
Key information
71.4%
Earnings growth rate
72.3%
EPS growth rate
Biotechs earnings growth | 25.9% |
Revenue growth rate | 14.3% |
Future return on equity | -3.8% |
Analyst coverage | Good |
Last updated | 30 Jul 2024 |
Recent future growth updates
Recent updates
Does Natera (NASDAQ:NTRA) Have A Healthy Balance Sheet?
Jul 05Natera: Overdue For A Breather
Jun 03Natera, Inc. (NASDAQ:NTRA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$119
May 12Is There An Opportunity With Natera, Inc.'s (NASDAQ:NTRA) 41% Undervaluation?
Mar 30Natera: Capitalizing On The Positive Momentum Of Personalized Medicine
Mar 22Is Natera (NASDAQ:NTRA) A Risky Investment?
Mar 03Estimating The Fair Value Of Natera, Inc. (NASDAQ:NTRA)
Dec 11Is Natera (NASDAQ:NTRA) A Risky Investment?
Nov 10Natera, Inc. (NASDAQ:NTRA) Shares Could Be 46% Below Their Intrinsic Value Estimate
Aug 07Health Check: How Prudently Does Natera (NASDAQ:NTRA) Use Debt?
May 16Natera, Inc.'s (NASDAQ:NTRA) Low P/S No Reason For Excitement
Apr 18Natera: Cracks In The Bearish Trade
Oct 10Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,977 | 0 | 134 | 359 | 11 |
12/31/2025 | 1,685 | -131 | 22 | 138 | 18 |
12/31/2024 | 1,435 | -297 | -144 | 50 | 18 |
3/31/2024 | 1,209 | -365 | -197 | -139 | N/A |
12/31/2023 | 1,083 | -435 | -286 | -247 | N/A |
9/30/2023 | 989 | -499 | -311 | -270 | N/A |
6/30/2023 | 931 | -512 | -387 | -343 | N/A |
3/31/2023 | 868 | -546 | -419 | -375 | N/A |
12/31/2022 | 820 | -548 | -479 | -432 | N/A |
9/30/2022 | 776 | -546 | -498 | -449 | N/A |
6/30/2022 | 723 | -576 | -492 | -438 | N/A |
3/31/2022 | 667 | -546 | -453 | -398 | N/A |
12/31/2021 | 625 | -472 | -385 | -335 | N/A |
9/30/2021 | 565 | -408 | -354 | -310 | N/A |
6/30/2021 | 505 | -315 | -280 | -252 | N/A |
3/31/2021 | 449 | -258 | -244 | -222 | N/A |
12/31/2020 | 391 | -230 | -202 | -183 | N/A |
9/30/2020 | 362 | -189 | -139 | -124 | N/A |
6/30/2020 | 342 | -153 | -117 | -104 | N/A |
3/31/2020 | 330 | -126 | -79 | -67 | N/A |
12/31/2019 | 302 | -125 | -68 | -63 | N/A |
9/30/2019 | 286 | -121 | -66 | -61 | N/A |
6/30/2019 | 273 | -128 | -76 | -72 | N/A |
3/31/2019 | 262 | -129 | -107 | -103 | N/A |
12/31/2018 | 258 | -128 | -74 | -71 | N/A |
9/30/2018 | 243 | -144 | -88 | -86 | N/A |
6/30/2018 | 233 | -142 | -97 | -94 | N/A |
3/31/2018 | 223 | -137 | -77 | -72 | N/A |
12/31/2017 | 210 | -138 | N/A | -98 | N/A |
9/30/2017 | 207 | -128 | N/A | -99 | N/A |
6/30/2017 | 205 | -126 | N/A | -92 | N/A |
3/31/2017 | 205 | -121 | N/A | -99 | N/A |
12/31/2016 | 213 | -100 | N/A | -74 | N/A |
9/30/2016 | 221 | -81 | N/A | -49 | N/A |
6/30/2016 | 212 | -72 | N/A | -42 | N/A |
3/31/2016 | 205 | -69 | N/A | -35 | N/A |
12/31/2015 | 190 | -70 | N/A | -38 | N/A |
9/30/2015 | 187 | -46 | N/A | -23 | N/A |
6/30/2015 | 189 | -28 | N/A | 0 | N/A |
3/31/2015 | 179 | -6 | N/A | 13 | N/A |
12/31/2014 | 159 | -5 | N/A | 10 | N/A |
9/30/2014 | 133 | -11 | N/A | -4 | N/A |
3/31/2014 | 78 | -29 | N/A | -20 | N/A |
12/31/2013 | 55 | -37 | N/A | -24 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NTRA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).
Earnings vs Market: NTRA is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: NTRA is expected to become profitable in the next 3 years.
Revenue vs Market: NTRA's revenue (14.3% per year) is forecast to grow faster than the US market (8.6% per year).
High Growth Revenue: NTRA's revenue (14.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NTRA is forecast to be unprofitable in 3 years.